Announcements
Sidley Represents Restive Ventures in Formation of US$45 Million Restive Fund III
May 29, 2026
Sidley represented Restive Ventures in the formation of its third fund, Restive Fund III, which closed with US$45 million in commitments. Focused on investments in AI-related fintech companies, the fund attracted a new range of strategic investors, including banks and financial institutions, payments firms, and technology companies focused on AI innovation across the financial services sector.
Based in San Francisco, Restive Ventures invests in pre-seed and seed-stage companies at the intersection of financial services and emerging technologies. More information about the transaction is available here.
The Sidley team was led by Rob Carlson and included John Schaff, Yusuke Kubo, Andrea Villarreal, and Zhize Wang.
Contacts


Capabilities
Suggested News & Insights
Sidley, Innovation Endeavors, and Premji Happy Hour Reception at JPMTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027Sidley Represents Laza Medical in Its US$160 Million Series B Financing RoundNovember 4, 2026Sidley Represents Hanmi Pharm and Green Cross Biopharma in Licensing Agreement With BioMarinOctober 30, 2026Introducing SidleyCatalyst: Built to Accelerate GrowthOctober 28, 2026Sidley Represents Bolt Biotherapeutics in the Acquisition of Prana Therapies and Concurrent US$120 Million Private Placement FinancingOctober 26, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


